Inovio Pharmaceuticals (INO) has been beaten down lately with too much selling pressure. While the stock has lost 11.4% over the past four weeks, there is light at the end of the tunnel as it is now ...

Shares of Inovio Pharmaceuticals Inc. INO advanced 1.90% to $1.61 Friday, on what proved to be an all-around positive trading ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Inovio Pharmaceuticals, Inc.’s INO share price has surged by 10.67%, which has investors questioning if this is right time to sell.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Inovio Pharmaceuticals Inc. closed 89.14% below its 52-week high of $13.44, which the company reached on May 16th.

INO stock opened at $1.92 on Friday. Inovio Pharmaceuticals has a 52 week low of $1.74 and a 52 week high of $14.75. The firm’s fifty day moving average is $2.04 and its 200 day moving average ...

CEO Jacqui Shea highlighted that Inovio remains committed to transforming into a commercial-stage company, with a primary focus on advancing INO-3107, a DNA medicine for recurrent respiratory ...